Pages that link to "Q39421687"

The following pages link to A Double-blind Trial of the Effects of Candicidin on Patients with Benign Prostatic Hypertrophy (Q39421687):

Displaying 18 items.

• Cholesterol and benign prostate disease (Q33732687) (← links)
• Endocrine treatment of benign prostatichypertrophy: Current concepts (Q34571957) (← links)
• Benign prostatic hyperplasia and its treatment (Q36562843) (← links)
• Urodynamic effects of various treatment modalities for benign prostatic hyperplasia (Q36890588) (← links)
• The Results of Prostatectomy: A Symptomatic and Urodynamic Analysis of 152 Patients (Q39544057) (← links)
• Critical review of the diagnosis of prostatic obstruction (Q40392981) (← links)
• Who Needs a Prostatectomy? Review of a Waiting List (Q40491449) (← links)
• A clinical view of pressure-flow studies (Q40540620) (← links)
• A Double Blind Trial of Bromocryptine in the Treatment of Idiopathic Bladder Instability (Q41077093) (← links)
• The Assessment of Prostatic Obstruction from Urodynamic Measurements and from Residual Urine (Q41727393) (← links)
• Effects of cimetidine, progesterone, cannitracin and tolazoline on the weight and DNA content of the testosterone-induced hyperplastic prostate of the rat. (Q47188033) (← links)
• Voiding dysfunction in benign prostatic hyperplasia: trends, controversies and recent revelations. II. pathology and pathophysiology (Q48018328) (← links)
• Antiandrogenic treatment of benign prostatic hyperplasia: a placebo controlled trial. (Q55057826) (← links)
• Critical evaluation of transurethral resection and incision of the prostate (Q67653888) (← links)
• Definition of prostatic urethral obstruction (Q71678250) (← links)
• The Natural History of Untreated “Prostatism” (Q72653818) (← links)
• Candicidin treatment of prostatism: A prospective double-blind placebo-controlled study (Q72699741) (← links)
• [S2e guideline of the German urologists: Conservative and pharmacologic treatment of benign prostatic hyperplasia] (Q86590305) (← links)